Syra Health PE Ratio 2022-2025 | SYRA

Current and historical p/e ratio for Syra Health (SYRA) from 2022 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Syra Health PE ratio as of January 22, 2026 is 0.00.

Syra Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2026-01-21 0.08 0.00
2025-09-30 0.09 $-0.12 0.00
2025-06-30 0.11 $-0.16 0.00
2025-03-31 0.26 $-0.36 0.00
2024-12-31 0.41 $-0.54 0.00
2024-09-30 0.42 $-0.65 0.00
2024-06-30 1.37 $-0.67 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.001B $0.008B
Syra Health Corp. is a healthcare technology company. It offers products and services in digital health, behavioral and mental health, population health management, health education and healthcare workforce. Syra Health Corp. is based in CARMEL, Ind.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $36.120B 41.77
Tempus AI (TEM) United States $11.621B 0.00
Doximity (DOCS) United States $7.503B 30.89
Hims & Hers Health (HIMS) United States $6.577B 53.50
IRhythm Holdings (IRTC) United States $5.273B 0.00
Hinge Health (HNGE) United States $3.268B 0.00
Privia Health (PRVA) United States $2.903B 181.54
10x Genomics (TXG) United States $2.870B 0.00
Heartflow (HTFL) United States $2.857B 0.00
Inspire Medical Systems (INSP) United States $2.795B 46.25
Omnicell (OMCL) United States $2.265B 46.31
Azenta (AZTA) United States $1.857B 76.17
Enovis (ENOV) United States $1.354B 7.11
Clover Health Investments (CLOV) United States $1.354B 0.00
Schrodinger (SDGR) United States $1.210B 0.00
Butterfly Network (BFLY) United States $1.117B 0.00
Phreesia (PHR) United States $0.942B 0.00
Fulgent Genetics (FLGT) United States $0.861B 0.00
Talkspace (TALK) United States $0.633B 127.33
Standard BioTools (LAB) United States $0.631B 0.00
Claritev (CTEV) United States $0.477B 0.00
Evolent Health (EVH) United States $0.424B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.366B 0.00
Carlsmed (CARL) United States $0.352B 0.00
Zepp Health (ZEPP) Netherlands $0.331B 0.00
TruBridge (TBRG) United States $0.303B 13.90
Senseonics Holdings (SENS) United States $0.295B 0.00
CapsoVision (CV) United States $0.289B 0.00
KORU Medical Systems (KRMD) United States $0.264B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.187B 0.00
MDxHealth SA (MDXH) Belgium $0.183B 0.00
Health Catalyst (HCAT) United States $0.163B 0.00
Nyxoah SA (NYXH) Belgium $0.162B 0.00
CareCloud (CCLD) United States $0.124B 6.81
Outset Medical (OM) United States $0.094B 0.00
Pulmonx (LUNG) United States $0.077B 0.00
American Well (AMWL) United States $0.074B 0.00
NetraMark Holdings (AINMF) Canada $0.073B 0.00
Retrieve Medical Holdings (RMHI) United States $0.067B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
EUDA Health Holdings (EUDA) Singapore $0.062B 0.00
111 (YI) China $0.046B 0.00
Precipio (PRPO) United States $0.043B 0.00
Evaxion - (EVAX) Denmark $0.035B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Lunai Bioworks (LNAI) United States $0.020B 0.00
P3 Health Partners (PIII) United States $0.019B 0.00
Zhongchao (ZCMD) China $0.012B 0.00
HeartSciences (HSCS) United States $0.012B 0.00
PROFUSA (PFSA) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Movano (MOVE) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00